The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Pin1 is required for the Ser727 phosphorylation-dependent Stat3 activity
Abstract
Signal transducer and activator of transcription 3 (Stat3) belongs to a family of latent cytoplasmic transcription factors important for cytokine signaling. Stat3 is constitutively activated in various tumors, and activated Stat3 itself also acts as an oncogene. Transcriptional activity of Stat3 is controlled by Tyr-phosphorylation, followed by dimerization and nuclear translocation. However, phosphorylation on Ser727 is indispensable for its maximal transcriptional activity with unclear mechanism. Here, we report that peptidyl-prolyl cis/trans isomerase 1 (Pin1), which specifically recognizes the pSer/Thr-Pro motifs on its target proteins, interacts with Stat3 upon cytokine/growth factor stimulation. Overexpression of Pin1 promotes Stat3 transcriptional activity and target gene expression, as well as recruitment of transcription coactivator, p300. These effects, however, were compromised in the Pin1-deficient cells, and were totally dependent on the Ser727 phosphorylation site. Finally, we showed that Pin1 enhances Stat3-mediated epithelial-mesenchymal transition in breast cancer cells induced by oncostatin M. Our data reveal a novel, Ser727 phosphorylation-dependent, post-translational regulation mechanism for Stat3.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been reported that Pin1 regulates the functions of transcription factors, such as NFAT [2], STAT3 [3], and NF-κB [4] that play important roles in the immune system.”
From Prolyl Isomerase Pin1 Protects Mice from Endotoxin Shock (2011) · cites this paper as [3]
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 1×
“Tyr-phosphorylation of Stat3 leads to dimerization via reciprocal interaction between the SH2 domain and the phosphorylated Tyr705, then nuclear transport, DNA binding and regulation of target gene expression (Darnell et al., 1994).”
BackgroundDarnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Wen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
Epithelial–mesenchymal transitions in development and pathologies
Thiery, J. P. (2003) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2003.10.006 · Cited by 1,710
Enhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src Oncoprotein
Yu, C.-L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., & Jove, R. (1995) · Science · doi:10.1126/science.7541555 · Cited by 931
A human peptidyl–prolyl isomerase essential for regulation of mitosis
Lu, K. P., Hanes, S. D., & Hunter, T. (1996) · Nature · doi:10.1038/380544a0 · Cited by 908
Serine phosphorylation of STATs
Decker, T., & Kovarik, P. (2000) · Oncogene · doi:10.1038/sj.onc.1203481 · Cited by 887
Levy, D. E., & Lee, C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15650 · Cited by 834
Cited by
Sorted by citations
The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease
Lu, K. P., & Zhou, X. Z. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2261 · Cited by 682
Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer
Aggarwal, B. B., Kunnumakkara, A. B., Harikumar, K. B., Gupta, S. R., Tharakan, S. T., Koca, C., Dey, S., & Sung, B. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04911.x · Cited by 663
Bharadwaj, U., Kasembeli, M. M., Robinson, P., & Tweardy, D. J. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018440 · Cited by 314
“…transcription (Wen et al., 1995; Abe et al., 2001; Shen et al., 2004) most likely through recruiting coactivator proteins (Schuringa et al., 2001; Lufei et al., 2007; Lee et al., 2009a), e.g., JNK1/2-mediated pS-STAT3 following UVA irradiation, enhanced STAT3–DNA binding in epidermal JB6 cells…”
BackgroundThe isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target
Zhou, X. Z., & Lu, K. P. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.49 · Cited by 275
Prolyl isomerase Pin1 in cancer
Lu, Z., & Hunter, T. R. (2014) · Cell Research · doi:10.1038/cr.2014.109 · Cited by 205
Dominguez, E., Mauborgne, A., Mallet, J. J., Desclaux, M., & Pohl, M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5007-09.2010 · Cited by 204
Peptidyl-prolyl cis–trans isomerase Pin1 in ageing, cancer and Alzheimer disease
Lee, T. H., Pastorino, L., & Lu, K. P. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001906 · Cited by 185
Li, F., Rajendran, P., & Sethi, G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00874.x · Cited by 176
IL-6-STAT3 signaling and premature senescence
Kojima, H., Inoue, T., Kunimoto, H., & Nakajima, K. (2013) · JAK-STAT · doi:10.4161/jkst.25763 · Cited by 170
Toward a new STATe: The role of STATs in mitochondrial function
Meier, J. A., & Larner, A. C. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2013.12.005 · Cited by 171
Risha, Y., Minić, Z., Ghobadloo, S. M., & Berezovski, M. V. (2020) · Scientific Reports · doi:10.1038/s41598-020-70393-4 · Cited by 170
Prolyl isomerase Pin1: a promoter of cancer and a target for therapy
Chen, Y., Wu, Y., Yang, H., Li, X., Jie, M., Hu, C.-J., Wu, Y., Yang, S., & Yang, Y. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0844-y · Cited by 165
Farrell, A. S., Pelz, C., Wang, X., Daniel, C. J., Wang, Z., Su, Y., Janghorban, M., Zhang, X., Morgan, C. W., Impey, S., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01455-12 · Cited by 140
Qin, H. R., Kim, H., Kim, J., Hurt, E. M., Klarmann, G. J., Kawasaki, B. T., Serrat, M. A. D., & Farrar, W. L. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1125 · Cited by 139
Rajendran, P., Li, F., Manu, K. A., Shanmugam, M. K., Loo, S. Y., Kumar, A. P., & Sethi, G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01187.x · Cited by 131
Xie, Y., Kole, S., Precht, P., Pazin, M. J., & Bernier, M. (2009) · Endocrinology · doi:10.1210/en.2008-1241 · Cited by 126
Lu, S., Gao, Y., Huang, X., & Wang, X. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2305 · Cited by 113
Kim, K., Kim, G., Kim, J. Y., Yun, H. J., Lim, S.-C., & Choi, H. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu044 · Cited by 108
Huang, S., & Sinicrope, F. A. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1004 · Cited by 93
Wakahara, R., Kunimoto, H., Tanino, K., Kojima, H., Inoue, A., Shintaku, H., & Nakajima, K. (2012) · Genes to Cells · doi:10.1111/j.1365-2443.2011.01575.x · Cited by 95
Takahashi, K., Uchida, C., Shin, R.-W., Shimazaki, K., & Uchida, T. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7270-0 · Cited by 105
Self-citationProlyl isomerases in gene transcription
Hanes, S. D. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.10.028 · Cited by 87
Sorafenib inhibits growth and metastasis of hepatocellular carcinoma by blocking STAT3
Gu, F. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i34.3922 · Cited by 91
Lim, C. P., Phan, T. T., Lim, I. J., & Cao, X. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.337 · Cited by 83
Self-citationAtkinson, G. P., Nozell, S. E., Harrison, D. K., Stonecypher, M. S., Chen, D., & Benveniste, E. N. (2009) · Oncogene · doi:10.1038/onc.2009.232 · Cited by 75
Jiang, N., Liao, Y., Wang, M., Wang, Y., Wang, K., Guo, J., Wu, P., Zhong, B., Guo, T., & Wu, C. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02179-z · Cited by 75
14-3-3 modulation of the inflammatory response
Munier, C. C., Ottmann, C., & Perry, M. W. D. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105236 · Cited by 79
Nakatsu, Y., Sakoda, H., Kushiyama, A., Zhang, J., Ono, H., Fujishiro, M., Kikuchi, T., Fukushima, T., Yoneda, M., Ohno, H., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.206904 · Cited by 69
Self-citationHsu, F.-N., Chen, M., Lin, K., Peng, Y.-T., Li, P.-C., Lin, E., Chiang, M.-C., Hsieh, J., & Lin, H. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00615.2012 · Cited by 63
Cyclophilins contribute to Stat3 signaling and survival of multiple myeloma cells
Bauer, K., Kretzschmar, A., Cvijic, H., Blumert, C., Löffler, D., Brocke-Heidrich, K., Schiene-Fischer, C., Fischer, G., Sinz, A., Clevenger, C., et al. (2009) · Oncogene · doi:10.1038/onc.2009.142 · Cited by 55
Function of PIN1 in Cancer Development and Its Inhibitors as Cancer Therapeutics
Yu, J. H., Im, C. Y., & Min, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00120 · Cited by 56
Choi, H. J., Kim, J. H., Lim, S., Kim, G., Yun, H. J., & Choi, H. S. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13274 · Cited by 53
Sun, Q., Fan, G., Zhuo, Q., Dai, W., Zeng, Y., Ji, S., Xu, W., Liu, W., Hu, Q., Zhang, Z., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12816 · Cited by 51
PIN1 in breast development and cancer: a clinical perspective
Rustighi, A., Zannini, A., Campaner, E., Ciani, Y., Piazza, S., & Sal, G. D. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.122 · Cited by 50
Regulation of Cardiac Hypertrophic Signaling by Prolyl Isomerase Pin1
Toko, H., Konstandin, M. H., Doroudgar, S., Ormachea, L., Joyo, E., Joyo, A. Y., Din, S., Gude, N. A., Collins, B. L., Völkers, M., et al. (2013) · Circulation Research · doi:10.1161/circresaha.113.301084 · Cited by 49
Self-citationNakatsu, Y., Matsunaga, Y., Yamamotoya, T., Ueda, K., Inoue, Y., Mori, K., Sakoda, H., Fujishiro, M., Ono, H., Kushiyama, A., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091495 · Cited by 50
Role of oxidative stress in the process of vascular remodeling following coronary revascularization
Gallo, G., Pierelli, G., Forte, M., Coluccia, R., Volpe, M., & Rubattu, S. D. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.05.046 · Cited by 47
Prolyl Isomerase Pin1 in Human Cancer: Function, Mechanism, and Significance
Pu, W., Zheng, Y., & Peng, Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00168 · Cited by 49
Proline Isomerization: From the Chemistry and Biology to Therapeutic Opportunities
Gurung, D., Danielson, J. A., Tasnim, A., Zhang, J., Zou, Y., & Liu, J. (2023) · Biology · doi:10.3390/biology12071008 · Cited by 50
The role of Pin1 in the development and treatment of cancer
Min, S., Zhou, X. Z., & Lu, K. P. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0821-x · Cited by 41
Xie, L., Zeng, Y., Dai, Z., He, W., Ke, H.-Z., Lin, Q., Chen, Y., Bu, J., Lin, D., & Zheng, M. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.22220 · Cited by 41
A functional map of the human intrinsically disordered proteome
Pritišanac, I., Alderson, T. R., Kolarić, Đ., Zarin, T., Xie, S., Lu, A. X., Alam, A., Maqsood, A., Youn, J., Forman-Kay, J. D., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2604562123 · Cited by 38
Fujimoto, Y., Shiraki, T., Horiuchi, Y., Waku, T., Shigenaga, A., Otaka, A., Ikura, T., Igarashi, K., Aimoto, S., Tate, S.-I., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.055095 · Cited by 37
Nakada, S., Kuboki, S., Nojima, H., Yoshitomi, H., Furukawa, K., Takayashiki, T., Takano, S., Miyazaki, M., & Ohtsuka, M. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-018-07132-7 · Cited by 36
Regulation of hematopoietic cell development and function by Stat3
Pamela, A. H. (2009) · Frontiers in bioscience · doi:10.2741/3597 · Cited by 36
Oncogenic Hijacking of the PIN1 Signaling Network
Zannini, A., Rustighi, A., Campaner, E., & Sal, G. D. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00094 · Cited by 37
Zouein, F. A., Kurdi, M., & Booz, G. W. (2013) · JAK-STAT · doi:10.4161/jkst.24352 · Cited by 34
Nuclear import of Pin1 is mediated by a novel sequence in the PPIase domain
Lufei, C., & Cao, X. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.12.011 · Cited by 32
Self-citationvan Tiel, C. M., Kurakula, K., Koenis, D. S., van der Wal, E., & de Vries, C. J. M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.06.030 · Cited by 32
14-3-3ζ Interacts with Stat3 and Regulates Its Constitutive Activation in Multiple Myeloma Cells
Zhang, J., Chen, F., Li, W., Xiong, Q., Yang, M., Zheng, P., Li, C., Pei, J., & Ge, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029554 · Cited by 31
The role of the c-Jun N-terminal kinase 2-α-isoform in non-small cell lung carcinoma tumorigenesis
Nitta, R. T., Fitz, C. D. V., Chu, A., Mitra, S. S., Godwin, A. K., & Wong, A. J. (2010) · Oncogene · doi:10.1038/onc.2010.414 · Cited by 31
Lv, L., Zhang, J., Zhang, L., Xue, G., Wang, P., Meng, Q., & Liang, W. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12082 · Cited by 30
Roles of peptidyl-prolyl isomerase Pin1 in disease pathogenesis
Li, J., Mo, C., Guo, Y., Zhang, B., Feng, X., Si, Q., Wu, X., Zhao, Z., Gong, L., He, D., et al. (2021) · Theranostics · doi:10.7150/thno.45889 · Cited by 32
Lobo, V. J. S.-A., Doni, M., Verrecchia, A., Sanulli, S., Fagà, G., Piontini, A., Bianchi, M., Conacci‐Sorrell, M., Mazzarol, G., Peg, V., et al. (2013) · Oncogene · doi:10.1038/onc.2012.621 · Cited by 28
Signal Transduction in Cerebral Arteries after Subarachnoid Hemorrhage—A Phosphoproteomic Approach
Parker, B. L., Larsen, M. R., Edvinsson, L. I., & Povlsen, G. K. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.78 · Cited by 25
He, S., Li, L., Jin, R., & Lu, X. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00390 · Cited by 26
Dilworth, D., Gudavicius, G., Leung, A., & Nelson, C. J. (2012) · Biochemistry and Cell Biology · doi:10.1139/o11-045 · Cited by 25
Gougèlet, A., Mansuy, A., Blay, J., Alberti, L., & Vermot‐Desroches, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008026 · Cited by 24
Samanta, S. K., Lee, J., Hahm, E., & Singh, S. V. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22814 · Cited by 24
A Guide to PIN1 Function and Mutations Across Cancers
Boustani, M. E., Stefano, L. D., Caligiuri, I., Mouawad, N., Granchi, C., Canzonieri, V., Tuccinardi, T., Giordano, A., & Rizzolio, F. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01477 · Cited by 23
Faratian, D., Um, I., Wilson, D. S., Mullen, P., Langdon, S. P., & Harrison, D. J. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.01.014 · Cited by 19
The prolyl isomerase Pin1 regulates hypoxia-inducible transcription factor (HIF) activity
Jalouli, M., Déry, M.-A. C., Lafleur, V. N., Lamalice, L., Zhou, X. Z., Lu, K. P., & Richard, D. E. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.04.005 · Cited by 20
Pin1 promotes GR transactivation by enhancing recruitment to target genes
Poolman, T. M., Farrow, S. N., Matthews, L. C., Loudon, A. S. I., & Ray, D. W. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt624 · Cited by 21
Newton, V. A., Ramocki, N. M., Scull, B., Simmons, J. G., McNaughton, K. K., & Lund, P. K. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090684 · Cited by 20
Hu, X., & Chen, L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00179 · Cited by 19
Prabhavathy, D., Vijayalakshmi, R., Kanchana, M. P., & Karunagaran, D. (2014) · Cellular Immunology · doi:10.1016/j.cellimm.2014.09.005 · Cited by 18
Prolyl Isomerase Pin1 Protects Mice from Endotoxin Shock
Akiyama, H., Misawa, T., Ono, M., Uchida, C., & Uchida, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014656 · Cited by 17
“Taken together, we assume that Pin1 may up-regulate the production of IL-10 by accelerating the transcription activity of CREB/STAT3 and elevates the level of IL-6 specific IkBNS inhibitor in macrophages in response to LPS stimulation.”
BackgroundSelf-citationChou, X., Ma, K., Shen, Y. L., Min, Z., Wu, Q., & Sun, D. (2021) · Toxicology · doi:10.1016/j.tox.2021.152769 · Cited by 16
Ha- ras Oncogene–Induced Stat3 Phosphorylation Enhances Oncogenicity of the Cell
Yeh, H.-H., Raghavaraju, G., Chang, T., Chou, C.-Y., Su, W., & Liu, H. (2009) · DNA and Cell Biology · doi:10.1089/dna.2008.0762 · Cited by 16
Thymidine phosphorylase inhibits vascular smooth muscle cell proliferation via upregulation of STAT3
Yue, H., Tanaka, K., Furukawa, T., Karnik, S. S., & Li, W. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.05.025 · Cited by 13
Rogals, M. J., Greenwood, A. I., Kwon, J., Lu, K. P., & Nicholson, L. K. (2016) · FEBS Journal · doi:10.1111/febs.13943 · Cited by 18
Pin1 Plays Essential Roles in NASH Development by Modulating Multiple Target Proteins
Inoue, M.-K., Nakatsu, Y., Yamamotoya, T., Hasei, S., Kanamoto, M., Naitou, M., Matsunaga, Y., Sakoda, H., Fujishiro, M., Ono, H., et al. (2019) · Cells · doi:10.3390/cells8121545 · Cited by 16
Interleukin-34-CSF1R Signaling Axis Promotes Epithelial Cell Transformation and Breast Tumorigenesis
Poudel, M., Kim, G., Bhattarai, P. Y., Kim, J., & Choi, H. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052711 · Cited by 14
Everolimus-induced human keratinocytes toxicity is mediated by STAT3 inhibition
Yamamoto, K., Uda, A., Mukai, A., Yamashita, K., Kume, M., Makimoto, H., Bito, T., Nishigori, C., Hirano, T., & Hirai, M. (2013) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-32-83 · Cited by 16
Yan, L., Sun, X., Wang, Z., Song, M., & Zhang, Z. (2019) · Hormones and Behavior · doi:10.1016/j.yhbeh.2019.104638 · Cited by 13
Lacreusette, A., Barbieux, I., Nguyen, J., Pandolfino, M., Dréno, B., Jacques, Y., Godard, A., & Blanchard, F. (2008) · The Journal of Pathology · doi:10.1002/path.2490 · Cited by 12
Pin1-based diagnostic and therapeutic strategies for breast cancer
Wang, J.-Z., Liu, B., & Zhang, Y. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.12.005 · Cited by 12
Lu, K. P., & Zhou, X. Z. (2024) · Science Signaling · doi:10.1126/scisignal.adi8743 · Cited by 12
Pin1 liberates the human immunodeficiency virus type-1 (HIV-1): Must we stop it?
Hou, H., Wang, J.-Z., Liu, B., & Zhang, T. (2015) · Gene · doi:10.1016/j.gene.2015.04.049 · Cited by 11
Johnston, P. A., Sen, M., Hua, Y., Camarco, D. P., Shun, T. Y., Lazo, J. S., & Grandis, J. R. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7357-6_14 · Cited by 11
Analysis of the STAT3 interactome using in-situ biotinylation and SILAC
Blumert, C., Kalkhof, S., Brocke-Heidrich, K., Kohajda, T., von Bergen�, M., & Horn, F. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.08.021 · Cited by 10
Kim, G., Bhattarai, P. Y., & Choi, H. S. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01122-3 · Cited by 9
Co-activator SRC-1 is dispensable for transcriptional control by STAT3.
Cvijic, H., Bauer, K., Löffler, D., Pfeifer, G., Blumert, C., Kretzschmar, A., Henze, C., Brocke-Heidrich, K., & Horn, F. (2009) · Biochemical Journal · doi:10.1042/bj20081989 · Cited by 10
Mencalha, A. L., Corrêa, S., Salles, D. C., Rocher, B. D., Santiago, M. F., & Abdelhay, E. S. F. W. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-866 · Cited by 7
Zhou, X., Ning, Y., Wang, X., Xu, J., Liu, Y., Zhang, M., & Zhang, S. (2025) · Human Cell · doi:10.1007/s13577-025-01252-5 · Cited by 6
Lee, G. W., Hur, W., Kim, J., Park, D. J., KIM, S. M., Kang, B.-Y., Sung, P. S., & Yoon, S. K. (2021) · Anticancer Research · doi:10.21873/anticanres.14954 · Cited by 6
Pin1 maintains the effector program of pathogenic Th17 cells in autoimmune neuroinflammation
Fan, G., Li, G., Li, L., & Da, Y. (2024) · Journal of Autoimmunity · doi:10.1016/j.jaut.2024.103262 · Cited by 5
Pin1 induces the ADP-induced migration of human dental pulp cells through P2Y1 stabilization
Kim, S., Choi, H. S., & Ahn, S. (2016) · Oncotarget · doi:10.18632/oncotarget.13377 · Cited by 5
Fan, G., Wang, L., Xu, J. W., Jiang, P., Wang, W., Huang, Y., Lv, M., & Liu, S. (2018) · Biochemistry and Cell Biology · doi:10.1139/bcb-2017-0334 · Cited by 4
Chen, X., Dixit, K., Yang, Y., McDermott, M. I., Imam, H. T., Bankaitis, V. A., & Igumenova, T. I. (2024) · eLife · doi:10.7554/elife.92884 · Cited by 4
Wang, Y., & Peng, J. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.108054 · Cited by 3
Kim, H., Lee, D. S., Park, J. H., Hong, H., Choi, H. J., Kim, O., & Kim, S. (2024) · World Journal of Stem Cells · doi:10.4252/wjsc.v16.i11.956 · Cited by 2
Erdogan, S. S., Yilmaz, A. Y., & Kumbasar, A. (2024) · FEBS Letters · doi:10.1002/1873-3468.15010 · Cited by 1
Oncostatin M Contributes To Breast Tumor Metastasis
Covert, H. J. (2017) · doi:10.18122/b2541x · Cited by 1
Roles for Pin1 in Modulating Cells of the Innate Immune System
Barberi, T. J. (2011) · DukeSpace (Duke University)
Dhillon, J. (2010) · cIRcle (University of British Columbia) · doi:10.14288/1.0069973
Investigation of PIN1 as a Genetic Modifier in Li-Fraumeni Syndrome
Villani, A. (2015) · TSpace (University of Toronto)
Inhibition of peptidyl-prolyl isomerase (PIN1) and BRAF signaling to target melanoma.
Braun, C., Schneider, N., Pei, D., Bosserhoff, A., & Kuphal, S. (2019) · PubMed Central
FASN Negatively Regulates NF-kB/P65 Expression in Breast Cancer Cells by Disrupting Its Stability
Barlow, L. (2020) · IUScholarWorks (Indiana University) · doi:10.7912/c2/339
Metadata
- Authors
- Lufei, C., Koh, T. H., Uchida, T., & Cao, X.
- Affiliations
- Institute of Molecular and Cell Biology (SG)
- Tohoku University (JP)
- Corresponding author
- Cao, X
- ORCID
- Uchida, T
- Venue
- Oncogene
- Published
- 2007-06-11
- Volume
- 26
- Issue
- 55
- Pages
- 7656-7664
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1994638410
- Cited by
- 106
- References
- 33
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 6 · 2023: 2 · 2021: 6 · 2020: 10 · 2019: 7 · 2018: 5 · 2017: 2 · 2016: 6 · 2015: 3 · 2014: 9 · 2013: 11 · 2012: 5
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National University of Singapore
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- STAT3, Pin1, peptidyl-prolyl isomerase, post-translational regulation, P300, transcriptional activation, cytokine signaling, epithelial-mesenchymal transition, oncostatin M, breast cancer
- MeSH terms
- NIMA-Interacting Peptidylprolyl Isomerase, Animals, Chlorocebus aethiops, DNA, HeLa Cells, Humans, Phosphorylation, Serine, Transcription, Genetic, COS Cells, Peptidylprolyl Isomerase, Cell Proliferation, STAT3 Transcription Factor, p300-CBP Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review